Senator Investment Group LP Merck & Co., Inc. Transaction History

Senator Investment Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $16 Million - $17.7 Million	-155,000 Reduced 38.27%	250,000 $25.7 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $26.6 Million - $29 Million	-245,000 Reduced 37.69%	405,000 $46.7 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $66.9 Million - $74.7 Million	650,000 New	650,000 $69.2 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $152 Million - $166 Million	-2,000,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $34.9 Million - $40.8 Million	-500,000 Reduced 20.0%	2,000,000 $168 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $81.6 Million - $94.6 Million	-1,250,000 Reduced 33.33%	2,500,000 $191 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $55.1 Million - $64.8 Million	-955,000 Reduced 20.3%	3,750,000 $266 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $239 Million - $281 Million	4,705,000 New	4,705,000 $286 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.